FARALLON CAPITAL MANAGEMENT LLC - BETTER THERAPEUTICS INC ownership

BETTER THERAPEUTICS INC's ticker is and the CUSIP is 08773T104. A total of 16 filers reported holding BETTER THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
FARALLON CAPITAL MANAGEMENT LLC ownership history of BETTER THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$357,069
-29.8%
330,619
-52.7%
0.00%
-33.3%
Q1 2023$508,903
-44.1%
699,042
-14.1%
0.00%
-40.0%
Q4 2022$911,183
-48.2%
813,556
-18.6%
0.01%
-50.0%
Q3 2022$1,760,000
+12.8%
1,000,0000.0%0.01%
+11.1%
Q2 2022$1,560,000
-31.3%
1,000,000
-12.8%
0.01%
-18.2%
Q1 2022$2,272,000
-63.8%
1,147,400
-15.0%
0.01%
-64.5%
Q4 2021$6,278,0001,350,0000.03%
Other shareholders
BETTER THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
FARALLON CAPITAL MANAGEMENT LLC 1,000,000$1,560,0000.01%
Tower Research Capital LLC (TRC) 14,627$23,0000.00%
TWO SIGMA INVESTMENTS, LP 73,800$115,0000.00%
WELLS FARGO & COMPANY/MN 65$00.00%
NORTHERN TRUST CORP 16,703$26,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 37,944$59,0000.00%
STATE STREET CORP 45,200$71,0000.00%
MORGAN STANLEY 93,973$147,0000.00%
BlackRock Inc. 75,948$118,0000.00%
View complete list of BETTER THERAPEUTICS INC shareholders